UCB - Ebitda

Stock Price
270.20
Daily Change
-5.90 -2.14%
Monthly
4.32%
Yearly
48.38%
Q1 Forecast
269.39

UCB reported EUR1.03B in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Alcon AG USD 654M 404M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 288.02M 84.53M Jun/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Galapagos EUR -158.71M 177.84M Mar/2025
Genmab DKK 477M 101M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Orion EUR 343M 207.9M Dec/2025
Recordati EUR 247.15M 421K Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
UCB EUR 1.03B 334M Jun/2025
Unibail Rodamco EUR 1.02B 71.7M Dec/2024